Cardica Inc (CRDC) 0.89 $CRDC
Hot Stock: Cardica, Shares Drop 6.4% (CRDC)
Comtex SmarTrend(R) - Wed Apr 16, 11:39AM CDT
Cardica (NASDAQ:CRDC) is one of today's worst performing penny stocks, down 6.4% to $0.88 on 5.8x average daily volume. Cardica has traded 1.3 million shares thus far today, vs. average volume of 218,000 shares per day. The stock has underperformed the Dow (-6.4% to the Dow's 0.8%) and underperformed the S&P 500 (-6.4% to the S&P's 0.8%) during today's trading.
Cardica Prices Public Offering of Common Stock and Preferred Stock
PR Newswire - Wed Apr 16, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the pricing of an underwritten public offering of 32,500,000 shares of its common stock, offered at a price to the public of $0.85 per share, and 191,474 shares of its Series A convertible preferred stock, offered at a price to the public of $85.00 per share. The Series A convertible preferred stock is non-voting and is convertible into shares of Cardica common stock at a conversion rate of 100 shares of common stock for each share of Series A convertible preferred stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.98% of the total number of shares of Cardica common stock then outstanding unless the holder gives Cardica at least 61 days prior notice of an intent to convert into shares of common stock that would cause the holder to own more than 9.98% of the total number of shares of common stock then issued and outstanding. Cardica has also granted to the underwriters an option to purchase up to an additional 4,875,000 shares of common stock to cover overallotments.
Cardica Announces Completion Of First U.S. Procedure Using MicroCutter XCHANGE(TM) 30 Stapling Device
PR Newswire - Tue Mar 11, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Juan-Carlos Verdeja, M.D., F.A.C.S., completed the first surgical procedure in the United States using the MicroCutter XCHANGE(TM) 30 cutting and stapling device at West Kendall Baptist Hospital in Florida on March 3, 2014. The MicroCutter XCHANGE 30 is the only articulating five millimeter surgical stapler available today.
Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material
PR Newswire - Thu Feb 27, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroCutter XCHANGE(TM) 30 white cartridge for the stapling of thin tissue for use in multiple open or minimally-invasive surgical procedures for the transection, resection and/or creation of anastomoses in small and large intestine, as well as the transection of the appendix. In addition, Cardica obtained 510(k) clearance for an additional plastic material contained within the MicroCutter XCHANGE 30 blue cartridge for use in medium thickness tissue. This material was submitted as a Special Premarket Notification 510(k) for the MicroCutter XCHANGE 30 device, which received FDA clearance in January 2014. With these clearances received Cardica does not have any other submissions pending at the FDA.
Cardica Announces Fiscal 2014 Second Quarter Financial Results
PR Newswire - Tue Feb 04, 3:05PM CST
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal second quarter ended December 31, 2013. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica Inc. (CRDC) in Focus: Stock Moves 5.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:18AM CST
Cardica Inc. (CRDC) was a big mover last session, as the company saw its shares rise by almost 6% on the day.
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
PR Newswire - Tue Jan 28, 12:43PM CST
Nonin Medical, a leader in noninvasive medical monitoring, today announced that it has entered into a multi-year distribution agreement with Terumo Cardiovascular Group in Europe. As of January 2014, Terumo Cardiovascular Group will distribute Nonin's SenSmart(TM) Universal Oximetry System to all hospitals in the UK and Ireland. A similar distribution agreement between the two companies for the United States was announced in April 2013. Terumo manufactures and markets medical devices for the global cardiac surgery market.
Cardica To Announce Fiscal 2014 Second Quarter Financial Results On Tuesday, February 4, 2014
PR Newswire - Fri Jan 24, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2013, on Tuesday, February 4, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
The Entrust Group Sees Increase in Self-Directed IRAs and Launches Ground-Breaking Technologies in 2013
PR Newswire - Wed Jan 22, 5:00AM CST
The Entrust Group, Inc., a pioneer and acknowledged authority in self-direction, today announced its top stories for fiscal year 2013 and set a new standard for the self-directed IRA industry. Amid various media reports of increased investor interest in self-direction, The Entrust Group saw 14.62 percent net growth in new accounts in 2013. In addition to this growth, The Entrust Group launched innovative tools that provide individuals the ability to educate themselves and conduct alternative investment transactions at their convenience, from anywhere in the world.
Cardica Up 6.2%, Shares Break Through Resistance (CRDC)
Comtex SmarTrend(R) - Fri Jan 17, 10:43AM CST
Cardica (NASDAQ:CRDC) is one of today's best performing low-priced stocks, up 6.2% to $1.20 on 1.2x average daily volume. Cardica has traded 411,000 shares thus far today, vs. average volume of 355,000 shares per day. The stock has outperformed the Dow (6.2% to the Dow's 0.3%) and outperformed the S&P 500 (6.2% to the S&P's -0.1%) during today's trading.
Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
PR Newswire - Mon Jan 13, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it has appointed Liam Burns to the position of Vice President, Sales and Marketing.
Nasdaq stocks posting largest volume increases
AP - Thu Jan 09, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Cardica Receives 510(k) Clearance For MicroCutter XCHANGE(TM) 30 Cutting/Stapling Device
PR Newswire - Thu Jan 09, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it obtained 510(k) clearance of the MicroCutter XCHANGE(TM) 30 device and blue staple cartridge for medium thickness tissue from the U.S. Food and Drug Administration for use in multiple open or minimally-invasive surgical procedures for the transection, resection and/or creation of anastomoses in small and large intestine, as well as the transection of the appendix. The XCHANGE 30 is the smallest diameter cutting and stapling device available today, with articulation up to 80 degrees and single-handed operation.
Baxano Surgical (BAXS) Jumps: Stock Adds 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:51AM CST
Baxano Surgical, Inc. was a big mover last session, as its shares rose almost 8% on the day.
International Interventional Cardiology Devices Market Growth Analysis 2009-2015
M2 - Fri Jan 03, 6:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxbg2l/global) has announced the addition of the "nternational Interventional Cardiology Devices Market Growth Analysis 2009-2015" report to their offering. The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 241 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. Key Topics Covered: Interventional Cardiac Devices 1. Coronary Stents a. Drug Eluting Stents (DES) b. Bare Metal Stents (BMS) c. Absorbable Stents 2. PTCA Balloons a. FW Balloons b. Cable Wire Balloons c. Rx Balloons 3. Cardiac Catheters a. Guiding Catheters b. Angiography Catheters c. Inflation Devices & Accessories 4. Intravascular Ultrasound Catheters (IVUS) 5. Coronary Guidewires 6. Arteriotomy Closure Devices & 7. Introducer Sheaths and Others Companies Mentioned: - Abbott Vascular Devices - Abiomed, Inc. - Advansource Biomaterials - Aga Medical C - Atricure, Inc - Atrium Medical Corp. - Ats Medical, Inc. - Biophan Technologies, Inc. - Biosense Webster, Inc. - Boston Scientific - Cardiac Science Corp. - Cardiacassist, Inc. - Cardica, Inc. - Cardiomems, Inc. - Cook Group Incorporated - Cordis Corporation - Corpidev Technologies - Cryolife Inc. - Medtronic, Inc. For more information visit http://www.researchandmarkets.com/research/mxbg2l/global
Cardica Announces Commercial Availability of White Cartridge for MicroCutter XCHANGE(TM) 30 Cutting/Stapling Device
PR Newswire - Wed Dec 11, 10:10AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced the commercial availability of the white cartridge for its MicroCutter XCHANGE(TM) 30 in Europe. Following extensive product testing to confirm reliability and functionality, Cardica shipped its initial commercial batches of white cartridges to its European distributors. The white cartridge is designed to be used with the MicroCutter XCHANGE 30 to staple blood vessels and other small tissue structures during open and laparoscopic surgical procedures.
Global Electrophysiology (EP) Laboratory Devices - Market Growth Analysis, 2009-2015
PR Newswire Europe - Tue Nov 26, 9:35AM CST
DUBLIN, Nov. 26, 2013 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/kmz7tk/global [http://www.researchandmarkets.com/research/kmz7tk/global]) has announced the addition of the "Global Electrophysiology (EP) Laboratory Devices - Market Growth Analysis, 2009-2015" [http://www.researchandmarkets.com/research/kmz7tk/global] report to their offering.
Cardica Announces Fiscal 2014 First Quarter Financial Results
PR Newswire - Mon Nov 04, 2:20PM CST
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal first quarter ended September 30, 2013. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica To Announce Fiscal 2014 First Quarter Financial Results On Monday, November 4, 2013
PR Newswire - Mon Oct 21, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal first quarter ended September 30, 2013, on Monday, November 4, 2013, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica To Present At Craig-Hallum Alpha Select Conference
PR Newswire - Wed Sep 11, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and CEO, is scheduled to present a corporate overview and update at the 4th Annual Craig-Hallum Alpha Select Conference in New York on Thursday, September 26 at 1:25 p.m. Eastern Time.
Hot Stock: Cardica, Shares Drop 6.4% (CRDC)
Comtex SmarTrend(R) - Wed Apr 16, 11:39AM CDT
Cardica (NASDAQ:CRDC) is one of today's worst performing penny stocks, down 6.4% to $0.88 on 5.8x average daily volume. Cardica has traded 1.3 million shares thus far today, vs. average volume of 218,000 shares per day. The stock has underperformed the Dow (-6.4% to the Dow's 0.8%) and underperformed the S&P 500 (-6.4% to the S&P's 0.8%) during today's trading.
Cardica Prices Public Offering of Common Stock and Preferred Stock
PR Newswire - Wed Apr 16, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the pricing of an underwritten public offering of 32,500,000 shares of its common stock, offered at a price to the public of $0.85 per share, and 191,474 shares of its Series A convertible preferred stock, offered at a price to the public of $85.00 per share. The Series A convertible preferred stock is non-voting and is convertible into shares of Cardica common stock at a conversion rate of 100 shares of common stock for each share of Series A convertible preferred stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.98% of the total number of shares of Cardica common stock then outstanding unless the holder gives Cardica at least 61 days prior notice of an intent to convert into shares of common stock that would cause the holder to own more than 9.98% of the total number of shares of common stock then issued and outstanding. Cardica has also granted to the underwriters an option to purchase up to an additional 4,875,000 shares of common stock to cover overallotments.
Cardica Announces Completion Of First U.S. Procedure Using MicroCutter XCHANGE(TM) 30 Stapling Device
PR Newswire - Tue Mar 11, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Juan-Carlos Verdeja, M.D., F.A.C.S., completed the first surgical procedure in the United States using the MicroCutter XCHANGE(TM) 30 cutting and stapling device at West Kendall Baptist Hospital in Florida on March 3, 2014. The MicroCutter XCHANGE 30 is the only articulating five millimeter surgical stapler available today.
Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material
PR Newswire - Thu Feb 27, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroCutter XCHANGE(TM) 30 white cartridge for the stapling of thin tissue for use in multiple open or minimally-invasive surgical procedures for the transection, resection and/or creation of anastomoses in small and large intestine, as well as the transection of the appendix. In addition, Cardica obtained 510(k) clearance for an additional plastic material contained within the MicroCutter XCHANGE 30 blue cartridge for use in medium thickness tissue. This material was submitted as a Special Premarket Notification 510(k) for the MicroCutter XCHANGE 30 device, which received FDA clearance in January 2014. With these clearances received Cardica does not have any other submissions pending at the FDA.
Cardica Announces Fiscal 2014 Second Quarter Financial Results
PR Newswire - Tue Feb 04, 3:05PM CST
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal second quarter ended December 31, 2013. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica Inc. (CRDC) in Focus: Stock Moves 5.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:18AM CST
Cardica Inc. (CRDC) was a big mover last session, as the company saw its shares rise by almost 6% on the day.
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
PR Newswire - Tue Jan 28, 12:43PM CST
Nonin Medical, a leader in noninvasive medical monitoring, today announced that it has entered into a multi-year distribution agreement with Terumo Cardiovascular Group in Europe. As of January 2014, Terumo Cardiovascular Group will distribute Nonin's SenSmart(TM) Universal Oximetry System to all hospitals in the UK and Ireland. A similar distribution agreement between the two companies for the United States was announced in April 2013. Terumo manufactures and markets medical devices for the global cardiac surgery market.
Cardica To Announce Fiscal 2014 Second Quarter Financial Results On Tuesday, February 4, 2014
PR Newswire - Fri Jan 24, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2013, on Tuesday, February 4, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
The Entrust Group Sees Increase in Self-Directed IRAs and Launches Ground-Breaking Technologies in 2013
PR Newswire - Wed Jan 22, 5:00AM CST
The Entrust Group, Inc., a pioneer and acknowledged authority in self-direction, today announced its top stories for fiscal year 2013 and set a new standard for the self-directed IRA industry. Amid various media reports of increased investor interest in self-direction, The Entrust Group saw 14.62 percent net growth in new accounts in 2013. In addition to this growth, The Entrust Group launched innovative tools that provide individuals the ability to educate themselves and conduct alternative investment transactions at their convenience, from anywhere in the world.
Cardica Up 6.2%, Shares Break Through Resistance (CRDC)
Comtex SmarTrend(R) - Fri Jan 17, 10:43AM CST
Cardica (NASDAQ:CRDC) is one of today's best performing low-priced stocks, up 6.2% to $1.20 on 1.2x average daily volume. Cardica has traded 411,000 shares thus far today, vs. average volume of 355,000 shares per day. The stock has outperformed the Dow (6.2% to the Dow's 0.3%) and outperformed the S&P 500 (6.2% to the S&P's -0.1%) during today's trading.
Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
PR Newswire - Mon Jan 13, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it has appointed Liam Burns to the position of Vice President, Sales and Marketing.
Nasdaq stocks posting largest volume increases
AP - Thu Jan 09, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Cardica Receives 510(k) Clearance For MicroCutter XCHANGE(TM) 30 Cutting/Stapling Device
PR Newswire - Thu Jan 09, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it obtained 510(k) clearance of the MicroCutter XCHANGE(TM) 30 device and blue staple cartridge for medium thickness tissue from the U.S. Food and Drug Administration for use in multiple open or minimally-invasive surgical procedures for the transection, resection and/or creation of anastomoses in small and large intestine, as well as the transection of the appendix. The XCHANGE 30 is the smallest diameter cutting and stapling device available today, with articulation up to 80 degrees and single-handed operation.
Baxano Surgical (BAXS) Jumps: Stock Adds 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:51AM CST
Baxano Surgical, Inc. was a big mover last session, as its shares rose almost 8% on the day.
International Interventional Cardiology Devices Market Growth Analysis 2009-2015
M2 - Fri Jan 03, 6:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxbg2l/global) has announced the addition of the "nternational Interventional Cardiology Devices Market Growth Analysis 2009-2015" report to their offering. The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 241 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. Key Topics Covered: Interventional Cardiac Devices 1. Coronary Stents a. Drug Eluting Stents (DES) b. Bare Metal Stents (BMS) c. Absorbable Stents 2. PTCA Balloons a. FW Balloons b. Cable Wire Balloons c. Rx Balloons 3. Cardiac Catheters a. Guiding Catheters b. Angiography Catheters c. Inflation Devices & Accessories 4. Intravascular Ultrasound Catheters (IVUS) 5. Coronary Guidewires 6. Arteriotomy Closure Devices & 7. Introducer Sheaths and Others Companies Mentioned: - Abbott Vascular Devices - Abiomed, Inc. - Advansource Biomaterials - Aga Medical C - Atricure, Inc - Atrium Medical Corp. - Ats Medical, Inc. - Biophan Technologies, Inc. - Biosense Webster, Inc. - Boston Scientific - Cardiac Science Corp. - Cardiacassist, Inc. - Cardica, Inc. - Cardiomems, Inc. - Cook Group Incorporated - Cordis Corporation - Corpidev Technologies - Cryolife Inc. - Medtronic, Inc. For more information visit http://www.researchandmarkets.com/research/mxbg2l/global
Cardica Announces Commercial Availability of White Cartridge for MicroCutter XCHANGE(TM) 30 Cutting/Stapling Device
PR Newswire - Wed Dec 11, 10:10AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced the commercial availability of the white cartridge for its MicroCutter XCHANGE(TM) 30 in Europe. Following extensive product testing to confirm reliability and functionality, Cardica shipped its initial commercial batches of white cartridges to its European distributors. The white cartridge is designed to be used with the MicroCutter XCHANGE 30 to staple blood vessels and other small tissue structures during open and laparoscopic surgical procedures.
Global Electrophysiology (EP) Laboratory Devices - Market Growth Analysis, 2009-2015
PR Newswire Europe - Tue Nov 26, 9:35AM CST
DUBLIN, Nov. 26, 2013 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/kmz7tk/global [http://www.researchandmarkets.com/research/kmz7tk/global]) has announced the addition of the "Global Electrophysiology (EP) Laboratory Devices - Market Growth Analysis, 2009-2015" [http://www.researchandmarkets.com/research/kmz7tk/global] report to their offering.
Cardica Announces Fiscal 2014 First Quarter Financial Results
PR Newswire - Mon Nov 04, 2:20PM CST
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal first quarter ended September 30, 2013. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica To Announce Fiscal 2014 First Quarter Financial Results On Monday, November 4, 2013
PR Newswire - Mon Oct 21, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal first quarter ended September 30, 2013, on Monday, November 4, 2013, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica To Present At Craig-Hallum Alpha Select Conference
PR Newswire - Wed Sep 11, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and CEO, is scheduled to present a corporate overview and update at the 4th Annual Craig-Hallum Alpha Select Conference in New York on Thursday, September 26 at 1:25 p.m. Eastern Time.
